This trial was designed to quantify the production of new red blood cells (RBCs) after treatment with recombinant human erythropoietin (r-HuEPO)

Braga, M., Gianotti, L., Gentilini, O., Vignali, A., Di Carlo, V. (1997). Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. HEPATO-GASTROENTEROLOGY, 44(15), 685-690.

Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery

Braga, M;GIANOTTI, LUCA VITTORIO;
1997

Abstract

This trial was designed to quantify the production of new red blood cells (RBCs) after treatment with recombinant human erythropoietin (r-HuEPO)
Articolo in rivista - Articolo scientifico
Preoperative Care; Erythropoiesis; Recombinant Proteins; Erythrocyte Count; Humans; Anemia; Aged; Prospective Studies; Erythropoietin; Cost-Benefit Analysis; Adult; Blood Transfusion; Gastrointestinal Neoplasms; Hematocrit; Middle Aged; Iron; Male; Female; Ferritins
English
1997
44
15
685
690
none
Braga, M., Gianotti, L., Gentilini, O., Vignali, A., Di Carlo, V. (1997). Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. HEPATO-GASTROENTEROLOGY, 44(15), 685-690.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/37490
Citazioni
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 15
Social impact